nodes	percent_of_prediction	percent_of_DWPC	metapath
Cabazitaxel—prostate cancer—urinary bladder cancer	0.625	1	CtDrD
Cabazitaxel—ABCB1—Mitomycin—urinary bladder cancer	0.0254	0.122	CbGbCtD
Cabazitaxel—SLCO1B3—Methotrexate—urinary bladder cancer	0.0207	0.0994	CbGbCtD
Cabazitaxel—ABCG2—Fluorouracil—urinary bladder cancer	0.0173	0.0834	CbGbCtD
Cabazitaxel—ABCG2—Carboplatin—urinary bladder cancer	0.0172	0.0829	CbGbCtD
Cabazitaxel—ABCG2—Cisplatin—urinary bladder cancer	0.0147	0.0708	CbGbCtD
Cabazitaxel—ABCG2—Etoposide—urinary bladder cancer	0.0145	0.0696	CbGbCtD
Cabazitaxel—SLCO1B1—Methotrexate—urinary bladder cancer	0.012	0.0579	CbGbCtD
Cabazitaxel—CYP3A4—Thiotepa—urinary bladder cancer	0.0115	0.0555	CbGbCtD
Cabazitaxel—ABCG2—Doxorubicin—urinary bladder cancer	0.00986	0.0475	CbGbCtD
Cabazitaxel—ABCG2—Methotrexate—urinary bladder cancer	0.00955	0.046	CbGbCtD
Cabazitaxel—CYP2C8—Fluorouracil—urinary bladder cancer	0.00923	0.0444	CbGbCtD
Cabazitaxel—CYP3A5—Etoposide—urinary bladder cancer	0.00801	0.0386	CbGbCtD
Cabazitaxel—CYP2C8—Etoposide—urinary bladder cancer	0.0077	0.0371	CbGbCtD
Cabazitaxel—ABCB1—Gemcitabine—urinary bladder cancer	0.0073	0.0352	CbGbCtD
Cabazitaxel—ABCB1—Cisplatin—urinary bladder cancer	0.00531	0.0255	CbGbCtD
Cabazitaxel—ABCB1—Etoposide—urinary bladder cancer	0.00521	0.0251	CbGbCtD
Cabazitaxel—ABCB1—Doxorubicin—urinary bladder cancer	0.00356	0.0171	CbGbCtD
Cabazitaxel—ABCB1—Methotrexate—urinary bladder cancer	0.00345	0.0166	CbGbCtD
Cabazitaxel—CYP3A4—Etoposide—urinary bladder cancer	0.00312	0.015	CbGbCtD
Cabazitaxel—CYP3A4—Doxorubicin—urinary bladder cancer	0.00213	0.0103	CbGbCtD
Cabazitaxel—TUBA4A—prostate gland—urinary bladder cancer	0.00125	0.0318	CbGeAlD
Cabazitaxel—Docetaxel—EGFR—urinary bladder cancer	0.00114	1	CrCbGaD
Cabazitaxel—TUBA4A—seminal vesicle—urinary bladder cancer	0.00106	0.0269	CbGeAlD
Cabazitaxel—TUBB4A—prostate gland—urinary bladder cancer	0.001	0.0255	CbGeAlD
Cabazitaxel—TUBB2B—prostate gland—urinary bladder cancer	0.00097	0.0246	CbGeAlD
Cabazitaxel—TUBA4A—epithelium—urinary bladder cancer	0.00092	0.0233	CbGeAlD
Cabazitaxel—TUBB—prostate gland—urinary bladder cancer	0.000918	0.0233	CbGeAlD
Cabazitaxel—TUBB2A—prostate gland—urinary bladder cancer	0.000913	0.0232	CbGeAlD
Cabazitaxel—TUBB6—Zalcitabine—Gemcitabine—urinary bladder cancer	0.000908	0.582	CbGdCrCtD
Cabazitaxel—TUBB6—prostate gland—urinary bladder cancer	0.0009	0.0228	CbGeAlD
Cabazitaxel—CYP3A4—urine—urinary bladder cancer	0.000896	0.0227	CbGeAlD
Cabazitaxel—TUBA4A—smooth muscle tissue—urinary bladder cancer	0.000886	0.0225	CbGeAlD
Cabazitaxel—TUBA4A—renal system—urinary bladder cancer	0.000853	0.0217	CbGeAlD
Cabazitaxel—TUBA4A—urethra—urinary bladder cancer	0.000838	0.0213	CbGeAlD
Cabazitaxel—TUBB2B—seminal vesicle—urinary bladder cancer	0.00082	0.0208	CbGeAlD
Cabazitaxel—TUBB4B—prostate gland—urinary bladder cancer	0.000783	0.0199	CbGeAlD
Cabazitaxel—TUBB—seminal vesicle—urinary bladder cancer	0.000776	0.0197	CbGeAlD
Cabazitaxel—TUBB2A—seminal vesicle—urinary bladder cancer	0.000772	0.0196	CbGeAlD
Cabazitaxel—TUBB6—seminal vesicle—urinary bladder cancer	0.000761	0.0193	CbGeAlD
Cabazitaxel—SLCO1B3—vagina—urinary bladder cancer	0.000713	0.0181	CbGeAlD
Cabazitaxel—TUBB4A—renal system—urinary bladder cancer	0.000684	0.0174	CbGeAlD
Cabazitaxel—TUBA4A—female reproductive system—urinary bladder cancer	0.000683	0.0173	CbGeAlD
Cabazitaxel—TUBB4B—seminal vesicle—urinary bladder cancer	0.000662	0.0168	CbGeAlD
Cabazitaxel—TUBB6—epithelium—urinary bladder cancer	0.000661	0.0168	CbGeAlD
Cabazitaxel—TUBB2B—renal system—urinary bladder cancer	0.000661	0.0168	CbGeAlD
Cabazitaxel—TUBB—smooth muscle tissue—urinary bladder cancer	0.00065	0.0165	CbGeAlD
Cabazitaxel—TUBB2B—urethra—urinary bladder cancer	0.000649	0.0165	CbGeAlD
Cabazitaxel—TUBB2A—smooth muscle tissue—urinary bladder cancer	0.000646	0.0164	CbGeAlD
Cabazitaxel—TUBB6—smooth muscle tissue—urinary bladder cancer	0.000637	0.0162	CbGeAlD
Cabazitaxel—TUBA4A—vagina—urinary bladder cancer	0.000618	0.0157	CbGeAlD
Cabazitaxel—TUBB—urethra—urinary bladder cancer	0.000614	0.0156	CbGeAlD
Cabazitaxel—TUBB6—renal system—urinary bladder cancer	0.000614	0.0156	CbGeAlD
Cabazitaxel—TUBB2A—urethra—urinary bladder cancer	0.000611	0.0155	CbGeAlD
Cabazitaxel—TUBB6—urethra—urinary bladder cancer	0.000603	0.0153	CbGeAlD
Cabazitaxel—SLCO1B1—renal system—urinary bladder cancer	0.000569	0.0144	CbGeAlD
Cabazitaxel—TUBB4B—smooth muscle tissue—urinary bladder cancer	0.000554	0.0141	CbGeAlD
Cabazitaxel—TUBB4A—female reproductive system—urinary bladder cancer	0.000548	0.0139	CbGeAlD
Cabazitaxel—TUBB4B—renal system—urinary bladder cancer	0.000533	0.0135	CbGeAlD
Cabazitaxel—TUBB2B—female reproductive system—urinary bladder cancer	0.000529	0.0134	CbGeAlD
Cabazitaxel—TUBB4B—urethra—urinary bladder cancer	0.000524	0.0133	CbGeAlD
Cabazitaxel—TUBB2A—female reproductive system—urinary bladder cancer	0.000498	0.0126	CbGeAlD
Cabazitaxel—TUBB6—female reproductive system—urinary bladder cancer	0.000491	0.0125	CbGeAlD
Cabazitaxel—TUBB2B—vagina—urinary bladder cancer	0.000479	0.0121	CbGeAlD
Cabazitaxel—TUBB—Azacitidine—Gemcitabine—urinary bladder cancer	0.000462	0.296	CbGdCrCtD
Cabazitaxel—ABCG2—prostate gland—urinary bladder cancer	0.000462	0.0117	CbGeAlD
Cabazitaxel—SLCO1B1—female reproductive system—urinary bladder cancer	0.000456	0.0116	CbGeAlD
Cabazitaxel—TUBB—vagina—urinary bladder cancer	0.000453	0.0115	CbGeAlD
Cabazitaxel—TUBB2A—vagina—urinary bladder cancer	0.000451	0.0114	CbGeAlD
Cabazitaxel—TUBB6—vagina—urinary bladder cancer	0.000444	0.0113	CbGeAlD
Cabazitaxel—CYP3A5—prostate gland—urinary bladder cancer	0.000428	0.0109	CbGeAlD
Cabazitaxel—TUBB4B—female reproductive system—urinary bladder cancer	0.000427	0.0108	CbGeAlD
Cabazitaxel—TUBA4A—lymph node—urinary bladder cancer	0.0004	0.0101	CbGeAlD
Cabazitaxel—ABCG2—seminal vesicle—urinary bladder cancer	0.00039	0.00991	CbGeAlD
Cabazitaxel—TUBB4B—vagina—urinary bladder cancer	0.000386	0.0098	CbGeAlD
Cabazitaxel—CYP2C8—renal system—urinary bladder cancer	0.000324	0.00821	CbGeAlD
Cabazitaxel—TUBB4A—lymph node—urinary bladder cancer	0.00032	0.00813	CbGeAlD
Cabazitaxel—TUBB2B—lymph node—urinary bladder cancer	0.00031	0.00786	CbGeAlD
Cabazitaxel—ABCG2—urethra—urinary bladder cancer	0.000309	0.00784	CbGeAlD
Cabazitaxel—TUBB—lymph node—urinary bladder cancer	0.000293	0.00744	CbGeAlD
Cabazitaxel—CYP3A5—renal system—urinary bladder cancer	0.000292	0.00741	CbGeAlD
Cabazitaxel—TUBB2A—lymph node—urinary bladder cancer	0.000291	0.0074	CbGeAlD
Cabazitaxel—TUBB6—lymph node—urinary bladder cancer	0.000287	0.0073	CbGeAlD
Cabazitaxel—CYP2C8—female reproductive system—urinary bladder cancer	0.000259	0.00658	CbGeAlD
Cabazitaxel—TUBB4B—lymph node—urinary bladder cancer	0.00025	0.00634	CbGeAlD
Cabazitaxel—CYP2C8—vagina—urinary bladder cancer	0.000234	0.00595	CbGeAlD
Cabazitaxel—ABCG2—vagina—urinary bladder cancer	0.000228	0.00578	CbGeAlD
Cabazitaxel—ABCB1—prostate gland—urinary bladder cancer	0.000228	0.00578	CbGeAlD
Cabazitaxel—CYP3A4—renal system—urinary bladder cancer	0.000219	0.00556	CbGeAlD
Cabazitaxel—CYP3A5—vagina—urinary bladder cancer	0.000211	0.00537	CbGeAlD
Cabazitaxel—ABCB1—seminal vesicle—urinary bladder cancer	0.000192	0.00489	CbGeAlD
Cabazitaxel—TUBB6—Azacitidine—Gemcitabine—urinary bladder cancer	0.000191	0.122	CbGdCrCtD
Cabazitaxel—CYP3A4—female reproductive system—urinary bladder cancer	0.000175	0.00445	CbGeAlD
Cabazitaxel—ABCB1—epithelium—urinary bladder cancer	0.000167	0.00424	CbGeAlD
Cabazitaxel—ABCB1—renal system—urinary bladder cancer	0.000155	0.00394	CbGeAlD
Cabazitaxel—ABCB1—urethra—urinary bladder cancer	0.000152	0.00387	CbGeAlD
Cabazitaxel—ABCG2—lymph node—urinary bladder cancer	0.000147	0.00374	CbGeAlD
Cabazitaxel—ABCB1—female reproductive system—urinary bladder cancer	0.000124	0.00315	CbGeAlD
Cabazitaxel—ABCB1—vagina—urinary bladder cancer	0.000112	0.00285	CbGeAlD
Cabazitaxel—ABCB1—lymph node—urinary bladder cancer	7.27e-05	0.00184	CbGeAlD
Cabazitaxel—Abdominal distension—Doxorubicin—urinary bladder cancer	7.2e-05	0.00078	CcSEcCtD
Cabazitaxel—Upper respiratory tract infection—Epirubicin—urinary bladder cancer	7.19e-05	0.000778	CcSEcCtD
Cabazitaxel—Conjunctivitis—Methotrexate—urinary bladder cancer	7.16e-05	0.000776	CcSEcCtD
Cabazitaxel—Influenza—Doxorubicin—urinary bladder cancer	7.16e-05	0.000775	CcSEcCtD
Cabazitaxel—Pollakiuria—Epirubicin—urinary bladder cancer	7.14e-05	0.000774	CcSEcCtD
Cabazitaxel—Body temperature increased—Fluorouracil—urinary bladder cancer	7.14e-05	0.000773	CcSEcCtD
Cabazitaxel—Feeling abnormal—Cisplatin—urinary bladder cancer	7.06e-05	0.000764	CcSEcCtD
Cabazitaxel—Paraesthesia—Etoposide—urinary bladder cancer	7.05e-05	0.000763	CcSEcCtD
Cabazitaxel—Haematuria—Methotrexate—urinary bladder cancer	7.03e-05	0.000761	CcSEcCtD
Cabazitaxel—Weight decreased—Epirubicin—urinary bladder cancer	7e-05	0.000758	CcSEcCtD
Cabazitaxel—Dyspnoea—Etoposide—urinary bladder cancer	7e-05	0.000757	CcSEcCtD
Cabazitaxel—Hyperglycaemia—Epirubicin—urinary bladder cancer	6.98e-05	0.000755	CcSEcCtD
Cabazitaxel—Vomiting—Thiotepa—urinary bladder cancer	6.95e-05	0.000752	CcSEcCtD
Cabazitaxel—Pneumonia—Epirubicin—urinary bladder cancer	6.94e-05	0.000751	CcSEcCtD
Cabazitaxel—Infestation—Epirubicin—urinary bladder cancer	6.9e-05	0.000747	CcSEcCtD
Cabazitaxel—Infestation NOS—Epirubicin—urinary bladder cancer	6.9e-05	0.000747	CcSEcCtD
Cabazitaxel—Headache—Thiotepa—urinary bladder cancer	6.84e-05	0.000741	CcSEcCtD
Cabazitaxel—Decreased appetite—Etoposide—urinary bladder cancer	6.82e-05	0.000738	CcSEcCtD
Cabazitaxel—Renal failure—Epirubicin—urinary bladder cancer	6.78e-05	0.000734	CcSEcCtD
Cabazitaxel—Gastrointestinal disorder—Etoposide—urinary bladder cancer	6.77e-05	0.000733	CcSEcCtD
Cabazitaxel—Body temperature increased—Cisplatin—urinary bladder cancer	6.77e-05	0.000733	CcSEcCtD
Cabazitaxel—Fatigue—Etoposide—urinary bladder cancer	6.76e-05	0.000732	CcSEcCtD
Cabazitaxel—Neuropathy peripheral—Epirubicin—urinary bladder cancer	6.76e-05	0.000732	CcSEcCtD
Cabazitaxel—Pain—Etoposide—urinary bladder cancer	6.71e-05	0.000726	CcSEcCtD
Cabazitaxel—Constipation—Etoposide—urinary bladder cancer	6.71e-05	0.000726	CcSEcCtD
Cabazitaxel—Urinary tract infection—Epirubicin—urinary bladder cancer	6.7e-05	0.000726	CcSEcCtD
Cabazitaxel—Conjunctivitis—Epirubicin—urinary bladder cancer	6.7e-05	0.000726	CcSEcCtD
Cabazitaxel—Dysuria—Doxorubicin—urinary bladder cancer	6.69e-05	0.000725	CcSEcCtD
Cabazitaxel—Neutropenia—Doxorubicin—urinary bladder cancer	6.69e-05	0.000725	CcSEcCtD
Cabazitaxel—Hypersensitivity—Fluorouracil—urinary bladder cancer	6.66e-05	0.000721	CcSEcCtD
Cabazitaxel—Upper respiratory tract infection—Doxorubicin—urinary bladder cancer	6.65e-05	0.00072	CcSEcCtD
Cabazitaxel—Pollakiuria—Doxorubicin—urinary bladder cancer	6.61e-05	0.000716	CcSEcCtD
Cabazitaxel—Asthenia—Gemcitabine—urinary bladder cancer	6.59e-05	0.000714	CcSEcCtD
Cabazitaxel—Haematuria—Epirubicin—urinary bladder cancer	6.58e-05	0.000712	CcSEcCtD
Cabazitaxel—Urinary tract disorder—Methotrexate—urinary bladder cancer	6.53e-05	0.000707	CcSEcCtD
Cabazitaxel—Nausea—Thiotepa—urinary bladder cancer	6.49e-05	0.000702	CcSEcCtD
Cabazitaxel—Urethral disorder—Methotrexate—urinary bladder cancer	6.48e-05	0.000702	CcSEcCtD
Cabazitaxel—Weight decreased—Doxorubicin—urinary bladder cancer	6.47e-05	0.000701	CcSEcCtD
Cabazitaxel—Feeling abnormal—Etoposide—urinary bladder cancer	6.47e-05	0.0007	CcSEcCtD
Cabazitaxel—Hyperglycaemia—Doxorubicin—urinary bladder cancer	6.46e-05	0.000699	CcSEcCtD
Cabazitaxel—Pneumonia—Doxorubicin—urinary bladder cancer	6.42e-05	0.000695	CcSEcCtD
Cabazitaxel—Gastrointestinal pain—Etoposide—urinary bladder cancer	6.42e-05	0.000695	CcSEcCtD
Cabazitaxel—Infestation NOS—Doxorubicin—urinary bladder cancer	6.38e-05	0.000691	CcSEcCtD
Cabazitaxel—Infestation—Doxorubicin—urinary bladder cancer	6.38e-05	0.000691	CcSEcCtD
Cabazitaxel—Hypersensitivity—Cisplatin—urinary bladder cancer	6.31e-05	0.000683	CcSEcCtD
Cabazitaxel—Diarrhoea—Gemcitabine—urinary bladder cancer	6.29e-05	0.000681	CcSEcCtD
Cabazitaxel—Renal failure—Doxorubicin—urinary bladder cancer	6.27e-05	0.000679	CcSEcCtD
Cabazitaxel—Neuropathy peripheral—Doxorubicin—urinary bladder cancer	6.25e-05	0.000677	CcSEcCtD
Cabazitaxel—Abdominal pain—Etoposide—urinary bladder cancer	6.2e-05	0.000672	CcSEcCtD
Cabazitaxel—Body temperature increased—Etoposide—urinary bladder cancer	6.2e-05	0.000672	CcSEcCtD
Cabazitaxel—Conjunctivitis—Doxorubicin—urinary bladder cancer	6.2e-05	0.000672	CcSEcCtD
Cabazitaxel—Urinary tract infection—Doxorubicin—urinary bladder cancer	6.2e-05	0.000672	CcSEcCtD
Cabazitaxel—Eye disorder—Methotrexate—urinary bladder cancer	6.18e-05	0.000669	CcSEcCtD
Cabazitaxel—Diarrhoea—Fluorouracil—urinary bladder cancer	6.18e-05	0.000669	CcSEcCtD
Cabazitaxel—Tinnitus—Methotrexate—urinary bladder cancer	6.17e-05	0.000668	CcSEcCtD
Cabazitaxel—Hypoaesthesia—Epirubicin—urinary bladder cancer	6.16e-05	0.000667	CcSEcCtD
Cabazitaxel—Asthenia—Cisplatin—urinary bladder cancer	6.14e-05	0.000665	CcSEcCtD
Cabazitaxel—Cardiac disorder—Methotrexate—urinary bladder cancer	6.14e-05	0.000665	CcSEcCtD
Cabazitaxel—Urinary tract disorder—Epirubicin—urinary bladder cancer	6.11e-05	0.000662	CcSEcCtD
Cabazitaxel—Oedema peripheral—Epirubicin—urinary bladder cancer	6.1e-05	0.00066	CcSEcCtD
Cabazitaxel—Haematuria—Doxorubicin—urinary bladder cancer	6.08e-05	0.000659	CcSEcCtD
Cabazitaxel—Connective tissue disorder—Epirubicin—urinary bladder cancer	6.08e-05	0.000659	CcSEcCtD
Cabazitaxel—Urethral disorder—Epirubicin—urinary bladder cancer	6.07e-05	0.000657	CcSEcCtD
Cabazitaxel—Angiopathy—Methotrexate—urinary bladder cancer	6e-05	0.00065	CcSEcCtD
Cabazitaxel—Immune system disorder—Methotrexate—urinary bladder cancer	5.98e-05	0.000647	CcSEcCtD
Cabazitaxel—Dizziness—Fluorouracil—urinary bladder cancer	5.97e-05	0.000647	CcSEcCtD
Cabazitaxel—Mediastinal disorder—Methotrexate—urinary bladder cancer	5.96e-05	0.000645	CcSEcCtD
Cabazitaxel—Chills—Methotrexate—urinary bladder cancer	5.94e-05	0.000643	CcSEcCtD
Cabazitaxel—Diarrhoea—Cisplatin—urinary bladder cancer	5.86e-05	0.000634	CcSEcCtD
Cabazitaxel—Alopecia—Methotrexate—urinary bladder cancer	5.85e-05	0.000633	CcSEcCtD
Cabazitaxel—Vomiting—Gemcitabine—urinary bladder cancer	5.84e-05	0.000633	CcSEcCtD
Cabazitaxel—Mental disorder—Methotrexate—urinary bladder cancer	5.8e-05	0.000627	CcSEcCtD
Cabazitaxel—Eye disorder—Epirubicin—urinary bladder cancer	5.79e-05	0.000626	CcSEcCtD
Cabazitaxel—Hypersensitivity—Etoposide—urinary bladder cancer	5.78e-05	0.000626	CcSEcCtD
Cabazitaxel—Tinnitus—Epirubicin—urinary bladder cancer	5.77e-05	0.000625	CcSEcCtD
Cabazitaxel—Erythema—Methotrexate—urinary bladder cancer	5.76e-05	0.000623	CcSEcCtD
Cabazitaxel—Malnutrition—Methotrexate—urinary bladder cancer	5.76e-05	0.000623	CcSEcCtD
Cabazitaxel—Headache—Gemcitabine—urinary bladder cancer	5.76e-05	0.000623	CcSEcCtD
Cabazitaxel—Flushing—Epirubicin—urinary bladder cancer	5.75e-05	0.000622	CcSEcCtD
Cabazitaxel—Cardiac disorder—Epirubicin—urinary bladder cancer	5.75e-05	0.000622	CcSEcCtD
Cabazitaxel—Vomiting—Fluorouracil—urinary bladder cancer	5.74e-05	0.000622	CcSEcCtD
Cabazitaxel—Hypoaesthesia—Doxorubicin—urinary bladder cancer	5.7e-05	0.000617	CcSEcCtD
Cabazitaxel—Headache—Fluorouracil—urinary bladder cancer	5.66e-05	0.000613	CcSEcCtD
Cabazitaxel—Urinary tract disorder—Doxorubicin—urinary bladder cancer	5.66e-05	0.000612	CcSEcCtD
Cabazitaxel—Oedema peripheral—Doxorubicin—urinary bladder cancer	5.64e-05	0.000611	CcSEcCtD
Cabazitaxel—Dysgeusia—Methotrexate—urinary bladder cancer	5.64e-05	0.000611	CcSEcCtD
Cabazitaxel—Asthenia—Etoposide—urinary bladder cancer	5.63e-05	0.00061	CcSEcCtD
Cabazitaxel—Connective tissue disorder—Doxorubicin—urinary bladder cancer	5.63e-05	0.000609	CcSEcCtD
Cabazitaxel—Angiopathy—Epirubicin—urinary bladder cancer	5.62e-05	0.000608	CcSEcCtD
Cabazitaxel—Urethral disorder—Doxorubicin—urinary bladder cancer	5.62e-05	0.000608	CcSEcCtD
Cabazitaxel—Immune system disorder—Epirubicin—urinary bladder cancer	5.59e-05	0.000605	CcSEcCtD
Cabazitaxel—Mediastinal disorder—Epirubicin—urinary bladder cancer	5.58e-05	0.000604	CcSEcCtD
Cabazitaxel—Back pain—Methotrexate—urinary bladder cancer	5.57e-05	0.000603	CcSEcCtD
Cabazitaxel—Chills—Epirubicin—urinary bladder cancer	5.55e-05	0.000601	CcSEcCtD
Cabazitaxel—Arrhythmia—Epirubicin—urinary bladder cancer	5.53e-05	0.000599	CcSEcCtD
Cabazitaxel—Alopecia—Epirubicin—urinary bladder cancer	5.47e-05	0.000592	CcSEcCtD
Cabazitaxel—Nausea—Gemcitabine—urinary bladder cancer	5.46e-05	0.000591	CcSEcCtD
Cabazitaxel—Vomiting—Cisplatin—urinary bladder cancer	5.45e-05	0.00059	CcSEcCtD
Cabazitaxel—Mental disorder—Epirubicin—urinary bladder cancer	5.42e-05	0.000587	CcSEcCtD
Cabazitaxel—Malnutrition—Epirubicin—urinary bladder cancer	5.39e-05	0.000583	CcSEcCtD
Cabazitaxel—Erythema—Epirubicin—urinary bladder cancer	5.39e-05	0.000583	CcSEcCtD
Cabazitaxel—Diarrhoea—Etoposide—urinary bladder cancer	5.37e-05	0.000581	CcSEcCtD
Cabazitaxel—Nausea—Fluorouracil—urinary bladder cancer	5.37e-05	0.000581	CcSEcCtD
Cabazitaxel—Eye disorder—Doxorubicin—urinary bladder cancer	5.35e-05	0.00058	CcSEcCtD
Cabazitaxel—Ill-defined disorder—Methotrexate—urinary bladder cancer	5.34e-05	0.000578	CcSEcCtD
Cabazitaxel—Tinnitus—Doxorubicin—urinary bladder cancer	5.34e-05	0.000578	CcSEcCtD
Cabazitaxel—Anaemia—Methotrexate—urinary bladder cancer	5.32e-05	0.000576	CcSEcCtD
Cabazitaxel—Cardiac disorder—Doxorubicin—urinary bladder cancer	5.32e-05	0.000576	CcSEcCtD
Cabazitaxel—Flushing—Doxorubicin—urinary bladder cancer	5.32e-05	0.000576	CcSEcCtD
Cabazitaxel—Dysgeusia—Epirubicin—urinary bladder cancer	5.28e-05	0.000571	CcSEcCtD
Cabazitaxel—Back pain—Epirubicin—urinary bladder cancer	5.21e-05	0.000564	CcSEcCtD
Cabazitaxel—Angiopathy—Doxorubicin—urinary bladder cancer	5.2e-05	0.000563	CcSEcCtD
Cabazitaxel—Malaise—Methotrexate—urinary bladder cancer	5.19e-05	0.000562	CcSEcCtD
Cabazitaxel—Dizziness—Etoposide—urinary bladder cancer	5.19e-05	0.000562	CcSEcCtD
Cabazitaxel—Muscle spasms—Epirubicin—urinary bladder cancer	5.18e-05	0.000561	CcSEcCtD
Cabazitaxel—Immune system disorder—Doxorubicin—urinary bladder cancer	5.17e-05	0.00056	CcSEcCtD
Cabazitaxel—Vertigo—Methotrexate—urinary bladder cancer	5.17e-05	0.00056	CcSEcCtD
Cabazitaxel—Mediastinal disorder—Doxorubicin—urinary bladder cancer	5.16e-05	0.000559	CcSEcCtD
Cabazitaxel—Leukopenia—Methotrexate—urinary bladder cancer	5.15e-05	0.000558	CcSEcCtD
Cabazitaxel—Chills—Doxorubicin—urinary bladder cancer	5.14e-05	0.000556	CcSEcCtD
Cabazitaxel—Arrhythmia—Doxorubicin—urinary bladder cancer	5.12e-05	0.000554	CcSEcCtD
Cabazitaxel—Nausea—Cisplatin—urinary bladder cancer	5.09e-05	0.000551	CcSEcCtD
Cabazitaxel—Alopecia—Doxorubicin—urinary bladder cancer	5.06e-05	0.000548	CcSEcCtD
Cabazitaxel—Cough—Methotrexate—urinary bladder cancer	5.03e-05	0.000544	CcSEcCtD
Cabazitaxel—Mental disorder—Doxorubicin—urinary bladder cancer	5.02e-05	0.000543	CcSEcCtD
Cabazitaxel—Ill-defined disorder—Epirubicin—urinary bladder cancer	5e-05	0.000541	CcSEcCtD
Cabazitaxel—Vomiting—Etoposide—urinary bladder cancer	4.99e-05	0.00054	CcSEcCtD
Cabazitaxel—Erythema—Doxorubicin—urinary bladder cancer	4.99e-05	0.00054	CcSEcCtD
Cabazitaxel—Malnutrition—Doxorubicin—urinary bladder cancer	4.99e-05	0.00054	CcSEcCtD
Cabazitaxel—Anaemia—Epirubicin—urinary bladder cancer	4.98e-05	0.000539	CcSEcCtD
Cabazitaxel—Headache—Etoposide—urinary bladder cancer	4.92e-05	0.000532	CcSEcCtD
Cabazitaxel—Arthralgia—Methotrexate—urinary bladder cancer	4.9e-05	0.000531	CcSEcCtD
Cabazitaxel—Chest pain—Methotrexate—urinary bladder cancer	4.9e-05	0.000531	CcSEcCtD
Cabazitaxel—Myalgia—Methotrexate—urinary bladder cancer	4.9e-05	0.000531	CcSEcCtD
Cabazitaxel—Dysgeusia—Doxorubicin—urinary bladder cancer	4.88e-05	0.000529	CcSEcCtD
Cabazitaxel—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—urinary bladder cancer	4.87e-05	0.000527	CcSEcCtD
Cabazitaxel—Malaise—Epirubicin—urinary bladder cancer	4.86e-05	0.000526	CcSEcCtD
Cabazitaxel—Discomfort—Methotrexate—urinary bladder cancer	4.84e-05	0.000524	CcSEcCtD
Cabazitaxel—Vertigo—Epirubicin—urinary bladder cancer	4.84e-05	0.000524	CcSEcCtD
Cabazitaxel—Leukopenia—Epirubicin—urinary bladder cancer	4.82e-05	0.000522	CcSEcCtD
Cabazitaxel—Back pain—Doxorubicin—urinary bladder cancer	4.82e-05	0.000522	CcSEcCtD
Cabazitaxel—Muscle spasms—Doxorubicin—urinary bladder cancer	4.79e-05	0.000519	CcSEcCtD
Cabazitaxel—Confusional state—Methotrexate—urinary bladder cancer	4.74e-05	0.000513	CcSEcCtD
Cabazitaxel—Cough—Epirubicin—urinary bladder cancer	4.7e-05	0.000509	CcSEcCtD
Cabazitaxel—Infection—Methotrexate—urinary bladder cancer	4.67e-05	0.000506	CcSEcCtD
Cabazitaxel—Nausea—Etoposide—urinary bladder cancer	4.66e-05	0.000505	CcSEcCtD
Cabazitaxel—Hypertension—Epirubicin—urinary bladder cancer	4.65e-05	0.000504	CcSEcCtD
Cabazitaxel—Ill-defined disorder—Doxorubicin—urinary bladder cancer	4.63e-05	0.000501	CcSEcCtD
Cabazitaxel—Nervous system disorder—Methotrexate—urinary bladder cancer	4.61e-05	0.000499	CcSEcCtD
Cabazitaxel—Anaemia—Doxorubicin—urinary bladder cancer	4.61e-05	0.000499	CcSEcCtD
Cabazitaxel—Thrombocytopenia—Methotrexate—urinary bladder cancer	4.6e-05	0.000498	CcSEcCtD
Cabazitaxel—Arthralgia—Epirubicin—urinary bladder cancer	4.59e-05	0.000497	CcSEcCtD
Cabazitaxel—Myalgia—Epirubicin—urinary bladder cancer	4.59e-05	0.000497	CcSEcCtD
Cabazitaxel—Chest pain—Epirubicin—urinary bladder cancer	4.59e-05	0.000497	CcSEcCtD
Cabazitaxel—Anxiety—Epirubicin—urinary bladder cancer	4.57e-05	0.000495	CcSEcCtD
Cabazitaxel—Skin disorder—Methotrexate—urinary bladder cancer	4.57e-05	0.000494	CcSEcCtD
Cabazitaxel—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—urinary bladder cancer	4.56e-05	0.000493	CcSEcCtD
Cabazitaxel—Discomfort—Epirubicin—urinary bladder cancer	4.53e-05	0.000491	CcSEcCtD
Cabazitaxel—Malaise—Doxorubicin—urinary bladder cancer	4.5e-05	0.000487	CcSEcCtD
Cabazitaxel—Dry mouth—Epirubicin—urinary bladder cancer	4.49e-05	0.000486	CcSEcCtD
Cabazitaxel—Vertigo—Doxorubicin—urinary bladder cancer	4.48e-05	0.000485	CcSEcCtD
Cabazitaxel—Anorexia—Methotrexate—urinary bladder cancer	4.48e-05	0.000485	CcSEcCtD
Cabazitaxel—Leukopenia—Doxorubicin—urinary bladder cancer	4.46e-05	0.000483	CcSEcCtD
Cabazitaxel—Confusional state—Epirubicin—urinary bladder cancer	4.43e-05	0.00048	CcSEcCtD
Cabazitaxel—Oedema—Epirubicin—urinary bladder cancer	4.4e-05	0.000476	CcSEcCtD
Cabazitaxel—Hypotension—Methotrexate—urinary bladder cancer	4.39e-05	0.000475	CcSEcCtD
Cabazitaxel—Infection—Epirubicin—urinary bladder cancer	4.37e-05	0.000473	CcSEcCtD
Cabazitaxel—Cough—Doxorubicin—urinary bladder cancer	4.35e-05	0.000471	CcSEcCtD
Cabazitaxel—Nervous system disorder—Epirubicin—urinary bladder cancer	4.31e-05	0.000467	CcSEcCtD
Cabazitaxel—Thrombocytopenia—Epirubicin—urinary bladder cancer	4.31e-05	0.000466	CcSEcCtD
Cabazitaxel—Hypertension—Doxorubicin—urinary bladder cancer	4.31e-05	0.000466	CcSEcCtD
Cabazitaxel—Tachycardia—Epirubicin—urinary bladder cancer	4.29e-05	0.000465	CcSEcCtD
Cabazitaxel—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	4.28e-05	0.000464	CcSEcCtD
Cabazitaxel—Skin disorder—Epirubicin—urinary bladder cancer	4.27e-05	0.000463	CcSEcCtD
Cabazitaxel—Chest pain—Doxorubicin—urinary bladder cancer	4.25e-05	0.00046	CcSEcCtD
Cabazitaxel—Arthralgia—Doxorubicin—urinary bladder cancer	4.25e-05	0.00046	CcSEcCtD
Cabazitaxel—Myalgia—Doxorubicin—urinary bladder cancer	4.25e-05	0.00046	CcSEcCtD
Cabazitaxel—Anxiety—Doxorubicin—urinary bladder cancer	4.23e-05	0.000458	CcSEcCtD
Cabazitaxel—Paraesthesia—Methotrexate—urinary bladder cancer	4.22e-05	0.000457	CcSEcCtD
Cabazitaxel—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—urinary bladder cancer	4.22e-05	0.000456	CcSEcCtD
Cabazitaxel—Discomfort—Doxorubicin—urinary bladder cancer	4.19e-05	0.000454	CcSEcCtD
Cabazitaxel—Anorexia—Epirubicin—urinary bladder cancer	4.19e-05	0.000454	CcSEcCtD
Cabazitaxel—Dyspnoea—Methotrexate—urinary bladder cancer	4.19e-05	0.000454	CcSEcCtD
Cabazitaxel—Dry mouth—Doxorubicin—urinary bladder cancer	4.15e-05	0.00045	CcSEcCtD
Cabazitaxel—Dyspepsia—Methotrexate—urinary bladder cancer	4.14e-05	0.000448	CcSEcCtD
Cabazitaxel—Hypotension—Epirubicin—urinary bladder cancer	4.11e-05	0.000445	CcSEcCtD
Cabazitaxel—Confusional state—Doxorubicin—urinary bladder cancer	4.1e-05	0.000444	CcSEcCtD
Cabazitaxel—Decreased appetite—Methotrexate—urinary bladder cancer	4.09e-05	0.000442	CcSEcCtD
Cabazitaxel—Oedema—Doxorubicin—urinary bladder cancer	4.07e-05	0.000441	CcSEcCtD
Cabazitaxel—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	4.06e-05	0.000439	CcSEcCtD
Cabazitaxel—Fatigue—Methotrexate—urinary bladder cancer	4.05e-05	0.000439	CcSEcCtD
Cabazitaxel—Infection—Doxorubicin—urinary bladder cancer	4.04e-05	0.000438	CcSEcCtD
Cabazitaxel—Pain—Methotrexate—urinary bladder cancer	4.02e-05	0.000435	CcSEcCtD
Cabazitaxel—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	4.01e-05	0.000434	CcSEcCtD
Cabazitaxel—Nervous system disorder—Doxorubicin—urinary bladder cancer	3.99e-05	0.000432	CcSEcCtD
Cabazitaxel—Thrombocytopenia—Doxorubicin—urinary bladder cancer	3.98e-05	0.000431	CcSEcCtD
Cabazitaxel—Tachycardia—Doxorubicin—urinary bladder cancer	3.97e-05	0.00043	CcSEcCtD
Cabazitaxel—Skin disorder—Doxorubicin—urinary bladder cancer	3.95e-05	0.000428	CcSEcCtD
Cabazitaxel—Paraesthesia—Epirubicin—urinary bladder cancer	3.95e-05	0.000428	CcSEcCtD
Cabazitaxel—Dyspnoea—Epirubicin—urinary bladder cancer	3.92e-05	0.000425	CcSEcCtD
Cabazitaxel—Anorexia—Doxorubicin—urinary bladder cancer	3.88e-05	0.00042	CcSEcCtD
Cabazitaxel—Feeling abnormal—Methotrexate—urinary bladder cancer	3.87e-05	0.000419	CcSEcCtD
Cabazitaxel—Dyspepsia—Epirubicin—urinary bladder cancer	3.87e-05	0.000419	CcSEcCtD
Cabazitaxel—Gastrointestinal pain—Methotrexate—urinary bladder cancer	3.84e-05	0.000416	CcSEcCtD
Cabazitaxel—Decreased appetite—Epirubicin—urinary bladder cancer	3.82e-05	0.000414	CcSEcCtD
Cabazitaxel—Hypotension—Doxorubicin—urinary bladder cancer	3.8e-05	0.000412	CcSEcCtD
Cabazitaxel—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	3.8e-05	0.000411	CcSEcCtD
Cabazitaxel—Fatigue—Epirubicin—urinary bladder cancer	3.79e-05	0.000411	CcSEcCtD
Cabazitaxel—Pain—Epirubicin—urinary bladder cancer	3.76e-05	0.000407	CcSEcCtD
Cabazitaxel—Constipation—Epirubicin—urinary bladder cancer	3.76e-05	0.000407	CcSEcCtD
Cabazitaxel—Body temperature increased—Methotrexate—urinary bladder cancer	3.72e-05	0.000402	CcSEcCtD
Cabazitaxel—Abdominal pain—Methotrexate—urinary bladder cancer	3.72e-05	0.000402	CcSEcCtD
Cabazitaxel—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	3.71e-05	0.000401	CcSEcCtD
Cabazitaxel—Paraesthesia—Doxorubicin—urinary bladder cancer	3.65e-05	0.000396	CcSEcCtD
Cabazitaxel—Dyspnoea—Doxorubicin—urinary bladder cancer	3.63e-05	0.000393	CcSEcCtD
Cabazitaxel—Feeling abnormal—Epirubicin—urinary bladder cancer	3.62e-05	0.000392	CcSEcCtD
Cabazitaxel—Gastrointestinal pain—Epirubicin—urinary bladder cancer	3.6e-05	0.000389	CcSEcCtD
Cabazitaxel—Dyspepsia—Doxorubicin—urinary bladder cancer	3.58e-05	0.000388	CcSEcCtD
Cabazitaxel—Decreased appetite—Doxorubicin—urinary bladder cancer	3.54e-05	0.000383	CcSEcCtD
Cabazitaxel—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	3.51e-05	0.00038	CcSEcCtD
Cabazitaxel—Fatigue—Doxorubicin—urinary bladder cancer	3.51e-05	0.00038	CcSEcCtD
Cabazitaxel—Pain—Doxorubicin—urinary bladder cancer	3.48e-05	0.000377	CcSEcCtD
Cabazitaxel—Constipation—Doxorubicin—urinary bladder cancer	3.48e-05	0.000377	CcSEcCtD
Cabazitaxel—Abdominal pain—Epirubicin—urinary bladder cancer	3.48e-05	0.000376	CcSEcCtD
Cabazitaxel—Body temperature increased—Epirubicin—urinary bladder cancer	3.48e-05	0.000376	CcSEcCtD
Cabazitaxel—Hypersensitivity—Methotrexate—urinary bladder cancer	3.46e-05	0.000375	CcSEcCtD
Cabazitaxel—Asthenia—Methotrexate—urinary bladder cancer	3.37e-05	0.000365	CcSEcCtD
Cabazitaxel—Feeling abnormal—Doxorubicin—urinary bladder cancer	3.35e-05	0.000363	CcSEcCtD
Cabazitaxel—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	3.33e-05	0.00036	CcSEcCtD
Cabazitaxel—Hypersensitivity—Epirubicin—urinary bladder cancer	3.24e-05	0.000351	CcSEcCtD
Cabazitaxel—Abdominal pain—Doxorubicin—urinary bladder cancer	3.22e-05	0.000348	CcSEcCtD
Cabazitaxel—Body temperature increased—Doxorubicin—urinary bladder cancer	3.22e-05	0.000348	CcSEcCtD
Cabazitaxel—Diarrhoea—Methotrexate—urinary bladder cancer	3.22e-05	0.000348	CcSEcCtD
Cabazitaxel—Asthenia—Epirubicin—urinary bladder cancer	3.16e-05	0.000342	CcSEcCtD
Cabazitaxel—Dizziness—Methotrexate—urinary bladder cancer	3.11e-05	0.000336	CcSEcCtD
Cabazitaxel—Diarrhoea—Epirubicin—urinary bladder cancer	3.01e-05	0.000326	CcSEcCtD
Cabazitaxel—Hypersensitivity—Doxorubicin—urinary bladder cancer	3e-05	0.000325	CcSEcCtD
Cabazitaxel—Vomiting—Methotrexate—urinary bladder cancer	2.99e-05	0.000324	CcSEcCtD
Cabazitaxel—Headache—Methotrexate—urinary bladder cancer	2.94e-05	0.000319	CcSEcCtD
Cabazitaxel—Asthenia—Doxorubicin—urinary bladder cancer	2.92e-05	0.000316	CcSEcCtD
Cabazitaxel—Dizziness—Epirubicin—urinary bladder cancer	2.91e-05	0.000315	CcSEcCtD
Cabazitaxel—Vomiting—Epirubicin—urinary bladder cancer	2.8e-05	0.000303	CcSEcCtD
Cabazitaxel—Nausea—Methotrexate—urinary bladder cancer	2.79e-05	0.000302	CcSEcCtD
Cabazitaxel—Diarrhoea—Doxorubicin—urinary bladder cancer	2.78e-05	0.000301	CcSEcCtD
Cabazitaxel—Headache—Epirubicin—urinary bladder cancer	2.76e-05	0.000298	CcSEcCtD
Cabazitaxel—Dizziness—Doxorubicin—urinary bladder cancer	2.69e-05	0.000291	CcSEcCtD
Cabazitaxel—Nausea—Epirubicin—urinary bladder cancer	2.61e-05	0.000283	CcSEcCtD
Cabazitaxel—Vomiting—Doxorubicin—urinary bladder cancer	2.59e-05	0.00028	CcSEcCtD
Cabazitaxel—Headache—Doxorubicin—urinary bladder cancer	2.55e-05	0.000276	CcSEcCtD
Cabazitaxel—Nausea—Doxorubicin—urinary bladder cancer	2.42e-05	0.000262	CcSEcCtD
Cabazitaxel—ABCG2—Metabolism—PRSS3—urinary bladder cancer	1.68e-05	0.000515	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—GSTZ1—urinary bladder cancer	1.68e-05	0.000514	CbGpPWpGaD
Cabazitaxel—TUBB4B—Cell Cycle, Mitotic—CDKN2A—urinary bladder cancer	1.68e-05	0.000514	CbGpPWpGaD
Cabazitaxel—TUBB—Cell Cycle—CCND1—urinary bladder cancer	1.67e-05	0.000512	CbGpPWpGaD
Cabazitaxel—TUBB4A—Cell Cycle—CDKN2A—urinary bladder cancer	1.64e-05	0.000502	CbGpPWpGaD
Cabazitaxel—TUBB—Cell Cycle—CDKN1A—urinary bladder cancer	1.62e-05	0.000495	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—GSTO2—urinary bladder cancer	1.59e-05	0.000487	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—NAT1—urinary bladder cancer	1.59e-05	0.000487	CbGpPWpGaD
Cabazitaxel—TUBA4A—Cell Cycle—MYC—urinary bladder cancer	1.58e-05	0.000483	CbGpPWpGaD
Cabazitaxel—TUBB4B—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	1.57e-05	0.000481	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—urinary bladder cancer	1.57e-05	0.000479	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism—ENO2—urinary bladder cancer	1.56e-05	0.000479	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism—HPGDS—urinary bladder cancer	1.56e-05	0.000479	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	1.55e-05	0.000476	CbGpPWpGaD
Cabazitaxel—TUBB4A—Cell Cycle, Mitotic—CCND1—urinary bladder cancer	1.55e-05	0.000474	CbGpPWpGaD
Cabazitaxel—TUBA4A—Hemostasis—KRAS—urinary bladder cancer	1.54e-05	0.000473	CbGpPWpGaD
Cabazitaxel—TUBB4A—Metabolism of proteins—IGF1—urinary bladder cancer	1.54e-05	0.000472	CbGpPWpGaD
Cabazitaxel—TUBB—Cell Cycle—EP300—urinary bladder cancer	1.54e-05	0.000471	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism—GSTT1—urinary bladder cancer	1.52e-05	0.000464	CbGpPWpGaD
Cabazitaxel—ABCB1—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	1.51e-05	0.000462	CbGpPWpGaD
Cabazitaxel—TUBB2B—Metabolism of proteins—CXCL8—urinary bladder cancer	1.51e-05	0.000462	CbGpPWpGaD
Cabazitaxel—TUBB6—Metabolism of proteins—CXCL8—urinary bladder cancer	1.51e-05	0.000462	CbGpPWpGaD
Cabazitaxel—TUBB—Cell Cycle, Mitotic—MYC—urinary bladder cancer	1.5e-05	0.000459	CbGpPWpGaD
Cabazitaxel—TUBB4B—Cell Cycle—CDKN2A—urinary bladder cancer	1.5e-05	0.000459	CbGpPWpGaD
Cabazitaxel—TUBB4A—Cell Cycle, Mitotic—CDKN1A—urinary bladder cancer	1.5e-05	0.000459	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	1.49e-05	0.000457	CbGpPWpGaD
Cabazitaxel—TUBB3—Metabolism of proteins—CXCL8—urinary bladder cancer	1.46e-05	0.000446	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	1.46e-05	0.000446	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—UGT2B7—urinary bladder cancer	1.45e-05	0.000445	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—GSTZ1—urinary bladder cancer	1.45e-05	0.000445	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—TYMP—urinary bladder cancer	1.45e-05	0.000445	CbGpPWpGaD
Cabazitaxel—TUBB4A—Cell Cycle, Mitotic—EP300—urinary bladder cancer	1.43e-05	0.000437	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	1.42e-05	0.000435	CbGpPWpGaD
Cabazitaxel—TUBB4B—Cell Cycle, Mitotic—CCND1—urinary bladder cancer	1.42e-05	0.000434	CbGpPWpGaD
Cabazitaxel—TUBB2A—Metabolism of proteins—CXCL8—urinary bladder cancer	1.41e-05	0.000432	CbGpPWpGaD
Cabazitaxel—TUBB4B—Metabolism of proteins—IGF1—urinary bladder cancer	1.41e-05	0.000432	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	1.39e-05	0.000427	CbGpPWpGaD
Cabazitaxel—TUBB4A—Cell Cycle—CCND1—urinary bladder cancer	1.39e-05	0.000424	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—ATM—urinary bladder cancer	1.38e-05	0.000424	CbGpPWpGaD
Cabazitaxel—TUBB1—Metabolism of proteins—CXCL8—urinary bladder cancer	1.38e-05	0.000423	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—urinary bladder cancer	1.38e-05	0.000422	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—GSTO2—urinary bladder cancer	1.38e-05	0.000422	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—NAT1—urinary bladder cancer	1.38e-05	0.000422	CbGpPWpGaD
Cabazitaxel—TUBA4A—Hemostasis—TP53—urinary bladder cancer	1.37e-05	0.00042	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—urinary bladder cancer	1.37e-05	0.00042	CbGpPWpGaD
Cabazitaxel—TUBB4B—Cell Cycle, Mitotic—CDKN1A—urinary bladder cancer	1.37e-05	0.00042	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	1.35e-05	0.000415	CbGpPWpGaD
Cabazitaxel—ABCB1—Allograft Rejection—TNF—urinary bladder cancer	1.35e-05	0.000412	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—TYMP—urinary bladder cancer	1.34e-05	0.000412	CbGpPWpGaD
Cabazitaxel—TUBB—Cell Cycle—MYC—urinary bladder cancer	1.34e-05	0.000411	CbGpPWpGaD
Cabazitaxel—TUBB4A—Cell Cycle—CDKN1A—urinary bladder cancer	1.34e-05	0.00041	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—NAT2—urinary bladder cancer	1.31e-05	0.000402	CbGpPWpGaD
Cabazitaxel—TUBA4A—Hemostasis—HRAS—urinary bladder cancer	1.31e-05	0.000402	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—CYP4B1—urinary bladder cancer	1.31e-05	0.000401	CbGpPWpGaD
Cabazitaxel—TUBB4B—Cell Cycle, Mitotic—EP300—urinary bladder cancer	1.3e-05	0.000399	CbGpPWpGaD
Cabazitaxel—TUBA4A—Cell Cycle—TP53—urinary bladder cancer	1.29e-05	0.000397	CbGpPWpGaD
Cabazitaxel—TUBB4A—Cell Cycle—EP300—urinary bladder cancer	1.27e-05	0.000391	CbGpPWpGaD
Cabazitaxel—CYP3A4—Biological oxidations—GSTP1—urinary bladder cancer	1.27e-05	0.00039	CbGpPWpGaD
Cabazitaxel—TUBB4B—Cell Cycle—CCND1—urinary bladder cancer	1.27e-05	0.000388	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—GSTZ1—urinary bladder cancer	1.27e-05	0.000388	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—UGT2B7—urinary bladder cancer	1.26e-05	0.000386	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism—NQO1—urinary bladder cancer	1.26e-05	0.000386	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metapathway biotransformation—GSTP1—urinary bladder cancer	1.26e-05	0.000385	CbGpPWpGaD
Cabazitaxel—TUBB4A—Cell Cycle, Mitotic—MYC—urinary bladder cancer	1.24e-05	0.000381	CbGpPWpGaD
Cabazitaxel—TUBB4A—Metabolism of proteins—CXCL8—urinary bladder cancer	1.24e-05	0.00038	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—SLC19A1—urinary bladder cancer	1.24e-05	0.000379	CbGpPWpGaD
Cabazitaxel—TUBB4B—Cell Cycle—CDKN1A—urinary bladder cancer	1.23e-05	0.000375	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	1.22e-05	0.000374	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—NAT2—urinary bladder cancer	1.22e-05	0.000372	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—PRSS3—urinary bladder cancer	1.2e-05	0.000369	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—CREBBP—urinary bladder cancer	1.2e-05	0.000368	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—GSTO2—urinary bladder cancer	1.2e-05	0.000367	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—NAT1—urinary bladder cancer	1.2e-05	0.000367	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—urinary bladder cancer	1.19e-05	0.000364	CbGpPWpGaD
Cabazitaxel—CYP3A4—Biological oxidations—GSTM1—urinary bladder cancer	1.17e-05	0.000358	CbGpPWpGaD
Cabazitaxel—TUBB4B—Cell Cycle—EP300—urinary bladder cancer	1.17e-05	0.000357	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metapathway biotransformation—GSTM1—urinary bladder cancer	1.15e-05	0.000353	CbGpPWpGaD
Cabazitaxel—TUBB4B—Cell Cycle, Mitotic—MYC—urinary bladder cancer	1.14e-05	0.000348	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—CYP4B1—urinary bladder cancer	1.13e-05	0.000347	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—RRM2—urinary bladder cancer	1.13e-05	0.000347	CbGpPWpGaD
Cabazitaxel—TUBB4B—Metabolism of proteins—CXCL8—urinary bladder cancer	1.13e-05	0.000347	CbGpPWpGaD
Cabazitaxel—TUBB4A—Cell Cycle—MYC—urinary bladder cancer	1.11e-05	0.00034	CbGpPWpGaD
Cabazitaxel—TUBB—Cell Cycle—TP53—urinary bladder cancer	1.1e-05	0.000337	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—UGT2B7—urinary bladder cancer	1.1e-05	0.000336	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—SLC19A1—urinary bladder cancer	1.07e-05	0.000328	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	1.07e-05	0.000326	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism—GSTP1—urinary bladder cancer	1.05e-05	0.000322	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—ENO2—urinary bladder cancer	1.05e-05	0.000322	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—HPGDS—urinary bladder cancer	1.05e-05	0.000322	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—RRM2—urinary bladder cancer	1.05e-05	0.000321	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—PRSS3—urinary bladder cancer	1.04e-05	0.00032	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	1.04e-05	0.00032	CbGpPWpGaD
Cabazitaxel—ABCB1—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	1.02e-05	0.000312	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—GSTT1—urinary bladder cancer	1.02e-05	0.000312	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	1.02e-05	0.000311	CbGpPWpGaD
Cabazitaxel—TUBB4B—Cell Cycle—MYC—urinary bladder cancer	1.02e-05	0.000311	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—urinary bladder cancer	1.01e-05	0.000308	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	1e-05	0.000307	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—CYP4B1—urinary bladder cancer	9.88e-06	0.000303	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—urinary bladder cancer	9.84e-06	0.000301	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism—TYMS—urinary bladder cancer	9.77e-06	0.000299	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—ENO2—urinary bladder cancer	9.72e-06	0.000298	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—HPGDS—urinary bladder cancer	9.72e-06	0.000298	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism—NCOR1—urinary bladder cancer	9.65e-06	0.000296	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism—GSTM1—urinary bladder cancer	9.65e-06	0.000296	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—TYMP—urinary bladder cancer	9.63e-06	0.000295	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	9.53e-06	0.000292	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—GSTT1—urinary bladder cancer	9.43e-06	0.000289	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—SLC19A1—urinary bladder cancer	9.33e-06	0.000286	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism—GPX1—urinary bladder cancer	9.24e-06	0.000283	CbGpPWpGaD
Cabazitaxel—TUBB4A—Cell Cycle—TP53—urinary bladder cancer	9.12e-06	0.000279	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—PRSS3—urinary bladder cancer	9.09e-06	0.000279	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism—ERCC2—urinary bladder cancer	9.08e-06	0.000278	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—urinary bladder cancer	8.89e-06	0.000272	CbGpPWpGaD
Cabazitaxel—ABCG2—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	8.83e-06	0.00027	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—NAT2—urinary bladder cancer	8.71e-06	0.000267	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—urinary bladder cancer	8.6e-06	0.000264	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—urinary bladder cancer	8.58e-06	0.000263	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism—MTHFR—urinary bladder cancer	8.53e-06	0.000261	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—NQO1—urinary bladder cancer	8.46e-06	0.000259	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	8.37e-06	0.000256	CbGpPWpGaD
Cabazitaxel—TUBB4B—Cell Cycle—TP53—urinary bladder cancer	8.34e-06	0.000256	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—TYMP—urinary bladder cancer	8.34e-06	0.000256	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	8.21e-06	0.000251	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—urinary bladder cancer	8.19e-06	0.000251	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	8.01e-06	0.000245	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—urinary bladder cancer	7.96e-06	0.000244	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—NQO1—urinary bladder cancer	7.83e-06	0.00024	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—GSTZ1—urinary bladder cancer	7.8e-06	0.000239	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—NAT2—urinary bladder cancer	7.55e-06	0.000231	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—RRM2—urinary bladder cancer	7.52e-06	0.00023	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—GSTO2—urinary bladder cancer	7.39e-06	0.000226	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—NAT1—urinary bladder cancer	7.39e-06	0.000226	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—TYMP—urinary bladder cancer	7.27e-06	0.000223	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	7.16e-06	0.000219	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—urinary bladder cancer	7.13e-06	0.000218	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—GSTP1—urinary bladder cancer	7.06e-06	0.000216	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—urinary bladder cancer	6.98e-06	0.000214	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—HPGDS—urinary bladder cancer	6.96e-06	0.000213	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—ENO2—urinary bladder cancer	6.96e-06	0.000213	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism—PPARG—urinary bladder cancer	6.92e-06	0.000212	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	6.83e-06	0.000209	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—UGT2B7—urinary bladder cancer	6.76e-06	0.000207	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—GSTT1—urinary bladder cancer	6.75e-06	0.000207	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism—CREBBP—urinary bladder cancer	6.65e-06	0.000204	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—urinary bladder cancer	6.64e-06	0.000204	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—urinary bladder cancer	6.59e-06	0.000202	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—NAT2—urinary bladder cancer	6.57e-06	0.000201	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—TYMS—urinary bladder cancer	6.56e-06	0.000201	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—GSTP1—urinary bladder cancer	6.53e-06	0.0002	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—RRM2—urinary bladder cancer	6.51e-06	0.0002	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—NCOR1—urinary bladder cancer	6.49e-06	0.000199	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—GSTM1—urinary bladder cancer	6.49e-06	0.000199	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—GPX1—urinary bladder cancer	6.21e-06	0.00019	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—ERCC2—urinary bladder cancer	6.1e-06	0.000187	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—CYP4B1—urinary bladder cancer	6.09e-06	0.000186	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—TYMS—urinary bladder cancer	6.08e-06	0.000186	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—HPGDS—urinary bladder cancer	6.03e-06	0.000185	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—ENO2—urinary bladder cancer	6.03e-06	0.000185	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—NCOR1—urinary bladder cancer	6.01e-06	0.000184	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—GSTM1—urinary bladder cancer	6.01e-06	0.000184	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	6e-06	0.000184	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—urinary bladder cancer	5.86e-06	0.000179	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—GSTT1—urinary bladder cancer	5.85e-06	0.000179	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	5.76e-06	0.000176	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—GPX1—urinary bladder cancer	5.75e-06	0.000176	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—SLC19A1—urinary bladder cancer	5.75e-06	0.000176	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—MTHFR—urinary bladder cancer	5.73e-06	0.000176	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—RRM2—urinary bladder cancer	5.67e-06	0.000174	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—ERCC2—urinary bladder cancer	5.65e-06	0.000173	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—NQO1—urinary bladder cancer	5.61e-06	0.000172	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—PRSS3—urinary bladder cancer	5.6e-06	0.000172	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism—PTGS2—urinary bladder cancer	5.44e-06	0.000167	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—MTHFR—urinary bladder cancer	5.31e-06	0.000163	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—HPGDS—urinary bladder cancer	5.26e-06	0.000161	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—ENO2—urinary bladder cancer	5.26e-06	0.000161	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—GSTT1—urinary bladder cancer	5.1e-06	0.000156	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—NQO1—urinary bladder cancer	4.86e-06	0.000149	CbGpPWpGaD
Cabazitaxel—ABCB1—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	4.77e-06	0.000146	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism—PTEN—urinary bladder cancer	4.75e-06	0.000145	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	4.72e-06	0.000145	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—GSTP1—urinary bladder cancer	4.68e-06	0.000143	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—PPARG—urinary bladder cancer	4.65e-06	0.000142	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism—EP300—urinary bladder cancer	4.53e-06	0.000139	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—TYMP—urinary bladder cancer	4.48e-06	0.000137	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—CREBBP—urinary bladder cancer	4.46e-06	0.000137	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—TYMS—urinary bladder cancer	4.35e-06	0.000133	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—PPARG—urinary bladder cancer	4.3e-06	0.000132	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—GSTM1—urinary bladder cancer	4.3e-06	0.000132	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—NCOR1—urinary bladder cancer	4.3e-06	0.000132	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—NQO1—urinary bladder cancer	4.24e-06	0.00013	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—CREBBP—urinary bladder cancer	4.13e-06	0.000127	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—GPX1—urinary bladder cancer	4.12e-06	0.000126	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	4.11e-06	0.000126	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—GSTP1—urinary bladder cancer	4.06e-06	0.000124	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—NAT2—urinary bladder cancer	4.05e-06	0.000124	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—ERCC2—urinary bladder cancer	4.05e-06	0.000124	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	3.92e-06	0.00012	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—MTHFR—urinary bladder cancer	3.8e-06	0.000116	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—TYMS—urinary bladder cancer	3.77e-06	0.000115	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—GSTM1—urinary bladder cancer	3.73e-06	0.000114	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—NCOR1—urinary bladder cancer	3.73e-06	0.000114	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—PTGS2—urinary bladder cancer	3.66e-06	0.000112	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—GPX1—urinary bladder cancer	3.57e-06	0.000109	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—GSTP1—urinary bladder cancer	3.53e-06	0.000108	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—ERCC2—urinary bladder cancer	3.5e-06	0.000107	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—RRM2—urinary bladder cancer	3.5e-06	0.000107	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—PTGS2—urinary bladder cancer	3.39e-06	0.000104	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—MTHFR—urinary bladder cancer	3.29e-06	0.000101	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—TYMS—urinary bladder cancer	3.28e-06	0.000101	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—NCOR1—urinary bladder cancer	3.25e-06	9.94e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—GSTM1—urinary bladder cancer	3.25e-06	9.94e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—HPGDS—urinary bladder cancer	3.24e-06	9.92e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—ENO2—urinary bladder cancer	3.24e-06	9.92e-05	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—PTEN—urinary bladder cancer	3.19e-06	9.77e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—GSTT1—urinary bladder cancer	3.14e-06	9.62e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—GPX1—urinary bladder cancer	3.11e-06	9.52e-05	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—PPARG—urinary bladder cancer	3.08e-06	9.44e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—ERCC2—urinary bladder cancer	3.05e-06	9.35e-05	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—EP300—urinary bladder cancer	3.04e-06	9.31e-05	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—CREBBP—urinary bladder cancer	2.96e-06	9.07e-05	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—PTEN—urinary bladder cancer	2.95e-06	9.04e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—MTHFR—urinary bladder cancer	2.87e-06	8.79e-05	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—EP300—urinary bladder cancer	2.82e-06	8.62e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—PPARG—urinary bladder cancer	2.67e-06	8.18e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—NQO1—urinary bladder cancer	2.61e-06	7.99e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—CREBBP—urinary bladder cancer	2.57e-06	7.86e-05	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—PTGS2—urinary bladder cancer	2.43e-06	7.43e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—PPARG—urinary bladder cancer	2.33e-06	7.13e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—CREBBP—urinary bladder cancer	2.24e-06	6.85e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—GSTP1—urinary bladder cancer	2.18e-06	6.67e-05	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—PTEN—urinary bladder cancer	2.12e-06	6.48e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—PTGS2—urinary bladder cancer	2.1e-06	6.44e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—TYMS—urinary bladder cancer	2.02e-06	6.2e-05	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—EP300—urinary bladder cancer	2.02e-06	6.18e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—GSTM1—urinary bladder cancer	2e-06	6.13e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—NCOR1—urinary bladder cancer	2e-06	6.13e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—GPX1—urinary bladder cancer	1.92e-06	5.87e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—ERCC2—urinary bladder cancer	1.88e-06	5.76e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—PTEN—urinary bladder cancer	1.83e-06	5.61e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—PTGS2—urinary bladder cancer	1.83e-06	5.61e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—MTHFR—urinary bladder cancer	1.77e-06	5.42e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—EP300—urinary bladder cancer	1.75e-06	5.35e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—PTEN—urinary bladder cancer	1.6e-06	4.89e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—EP300—urinary bladder cancer	1.52e-06	4.66e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—PPARG—urinary bladder cancer	1.43e-06	4.39e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—CREBBP—urinary bladder cancer	1.38e-06	4.22e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—PTGS2—urinary bladder cancer	1.13e-06	3.45e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—PTEN—urinary bladder cancer	9.83e-07	3.01e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—EP300—urinary bladder cancer	9.38e-07	2.87e-05	CbGpPWpGaD
